Coeptis Therapeutics, Inc. (COEP)
NASDAQ: COEP · IEX Real-Time Price · USD
0.295
-0.002 (-0.71%)
Mar 28, 2024, 12:50 PM EDT - Market open

Coeptis Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Net Income
-21.27-37.57-13.45-9.16-0
Depreciation & Amortization
110.450.320
Share-Based Compensation
0.4801.900
Other Operating Activities
12.5532.76.615.70
Operating Cash Flow
-7.24-3.88-4.49-3.14-0
Other Investing Activities
---1.75--
Investing Cash Flow
00-1.7500
Share Issuance / Repurchase
5.293.279.891.070
Debt Issued / Paid
-0.58-2.42-1.621.830.09
Other Financing Activities
0.24.63-0.05--0.09
Financing Cash Flow
4.925.498.222.90
Net Cash Flow
-2.321.611.98-0.240
Free Cash Flow
-7.24-3.88-4.49-3.14-0
Free Cash Flow Margin
---5985.92%-10195.12%-
Free Cash Flow Per Share
-0.28-0.27-0.41-0.17-0.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).